Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Peyronie's Disease With Platelet-Rich Plasma: A Randomized, Double-blind, Placebo-controlled Clinical Trial

NCT07117955 is registered in ClinicalTrials.gov with Herlev Hospital as lead sponsor.

NCT NCT07117955
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07117955 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Peyronie's Disease With Platelet-Rich Plasma: A Randomized, Double-blind, Placebo-controlled Clinical Trial
Lead sponsor
Herlev Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
October 21, 2025
Completion date
September 1, 2028
Enrollment
84 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peyronies disease